Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 5 studies | 21% ± 4% | |
natural killer cell | 4 studies | 19% ± 5% | |
endothelial cell | 4 studies | 20% ± 6% | |
epithelial cell | 4 studies | 28% ± 11% | |
regulatory T cell | 4 studies | 19% ± 4% | |
squamous epithelial cell | 3 studies | 26% ± 11% | |
retinal ganglion cell | 3 studies | 31% ± 3% | |
kidney loop of Henle epithelial cell | 3 studies | 49% ± 12% | |
retinal pigment epithelial cell | 3 studies | 31% ± 10% | |
macrophage | 3 studies | 18% ± 1% | |
dendritic cell | 3 studies | 26% ± 8% |
Insufficient scRNA-seq data for expression of SLC5A3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 12567.40 | 653 / 653 | 96% | 67.43 | 579 / 605 |
ovary | 97% | 2100.07 | 175 / 180 | 96% | 15.12 | 414 / 430 |
lung | 98% | 2353.96 | 569 / 578 | 94% | 15.50 | 1088 / 1155 |
uterus | 99% | 2092.88 | 168 / 170 | 93% | 14.79 | 429 / 459 |
kidney | 100% | 4759.36 | 89 / 89 | 89% | 23.40 | 804 / 901 |
breast | 97% | 2216.62 | 447 / 459 | 91% | 13.96 | 1021 / 1118 |
skin | 99% | 2830.47 | 1787 / 1809 | 87% | 30.62 | 409 / 472 |
esophagus | 89% | 1428.75 | 1289 / 1445 | 96% | 12.87 | 176 / 183 |
intestine | 100% | 2512.89 | 962 / 966 | 84% | 7.81 | 443 / 527 |
bladder | 95% | 1773.71 | 20 / 21 | 87% | 11.55 | 438 / 504 |
stomach | 92% | 1825.09 | 331 / 359 | 85% | 9.24 | 244 / 286 |
brain | 80% | 1212.92 | 2123 / 2642 | 92% | 10.71 | 652 / 705 |
adrenal gland | 98% | 3422.36 | 253 / 258 | 73% | 6.42 | 168 / 230 |
prostate | 95% | 1437.67 | 233 / 245 | 69% | 5.12 | 347 / 502 |
liver | 87% | 1238.32 | 196 / 226 | 24% | 1.89 | 97 / 406 |
pancreas | 35% | 327.24 | 115 / 328 | 75% | 8.19 | 133 / 178 |
blood vessel | 100% | 5417.99 | 1330 / 1335 | 0% | 0 | 0 / 0 |
adipose | 98% | 3244.73 | 1180 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 87% | 13.32 | 39 / 45 |
spleen | 86% | 1128.49 | 208 / 241 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 86% | 12.06 | 25 / 29 |
eye | 0% | 0 | 0 / 0 | 66% | 7.13 | 53 / 80 |
heart | 47% | 582.08 | 401 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 38% | 1864.71 | 355 / 929 | 0% | 0 | 0 / 0 |
muscle | 32% | 656.80 | 253 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0015798 | Biological process | myo-inositol transport |
GO_1904659 | Biological process | glucose transmembrane transport |
GO_0150104 | Biological process | transport across blood-brain barrier |
GO_1903428 | Biological process | positive regulation of reactive oxygen species biosynthetic process |
GO_0043576 | Biological process | regulation of respiratory gaseous exchange |
GO_1904679 | Biological process | myo-inositol import across plasma membrane |
GO_0043085 | Biological process | positive regulation of catalytic activity |
GO_0015791 | Biological process | polyol transmembrane transport |
GO_1905477 | Biological process | positive regulation of protein localization to membrane |
GO_0007422 | Biological process | peripheral nervous system development |
GO_0015750 | Biological process | pentose transmembrane transport |
GO_0015756 | Biological process | fucose transmembrane transport |
GO_0006020 | Biological process | inositol metabolic process |
GO_0035725 | Biological process | sodium ion transmembrane transport |
GO_0016324 | Cellular component | apical plasma membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0016020 | Cellular component | membrane |
GO_0008076 | Cellular component | voltage-gated potassium channel complex |
GO_0016323 | Cellular component | basolateral plasma membrane |
GO_0015166 | Molecular function | polyol transmembrane transporter activity |
GO_0015150 | Molecular function | fucose transmembrane transporter activity |
GO_0005412 | Molecular function | glucose:sodium symporter activity |
GO_0015459 | Molecular function | potassium channel regulator activity |
GO_0044325 | Molecular function | transmembrane transporter binding |
GO_0005365 | Molecular function | myo-inositol transmembrane transporter activity |
GO_0005367 | Molecular function | myo-inositol:sodium symporter activity |
GO_0005515 | Molecular function | protein binding |
GO_0015146 | Molecular function | pentose transmembrane transporter activity |
Gene name | SLC5A3 |
Protein name | Sodium/myo-inositol cotransporter (Na(+)/myo-inositol cotransporter) (Sodium/myo-inositol transporter 1) (SMIT1) (Solute carrier family 5 member 3) |
Synonyms | |
Description | FUNCTION: Electrogenic Na(+)-coupled sugar symporter that actively transports myo-inositol and its stereoisomer scyllo-inositol across the plasma membrane, with a Na(+) to sugar coupling ratio of 2:1 (By similarity). Maintains myo-inositol concentration gradient that defines cell volume and fluid balance during osmotic stress, in particular in the fetoplacental unit and central nervous system (By similarity). Forms coregulatory complexes with voltage-gated K(+) ion channels, allosterically altering ion selectivity, voltage dependence and gating kinetics of the channel. In turn, K(+) efflux through the channel forms a local electrical gradient that modulates electrogenic Na(+)-coupled myo-inositol influx through the transporter . Associates with KCNQ1-KCNE2 channel in the apical membrane of choroid plexus epithelium and regulates the myo-inositol gradient between blood and cerebrospinal fluid with an impact on neuron excitability (By similarity). Associates with KCNQ2-KCNQ3 channel altering ion selectivity, increasing Na(+) and Cs(+) permeation relative to K(+) permeation . Provides myo-inositol precursor for biosynthesis of phosphoinositides such as PI(4,5)P2, thus indirectly affecting the activity of phosphoinositide-dependent ion channels and Ca(2+) signaling upon osmotic stress . . |
Accessions | ENST00000381151.5 P53794 |